HYD LLC

Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy

Two review papers consolidate 30 years of research BUDAPEST, Hungary, July 25, 2024 / Biotech Newswire / -- HYD LLC for Cancer Research and Drug Development (HYD or the Company) today announces two independent review papers in Nutrients -  Deuterium-Depleted Water in Cancer Therapy: A Systematic Review of Clinical and Experimental Trials and Frontiers in...
1118 Budapest, Villányi út 97., Hungary

+36 (1) 365-1660